Therapeutic options for hemarthrosis in severe hemophilic patients
the coagulation factors VIII (FVIII) or IX (FIX), respectively. The primary therapeutic approach is to replace the deficient coagulation factor, which can be achieved with factors derived from human plasma or recombinants. However, despite having a therapeutic approach, most severe cases are sympto...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | Portuguese |
| Published: |
Universidade de São Paulo
2022-12-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.revistas.usp.br/rmrp/article/view/196511 |